Skip Navigation

Annals of Oncology 2004 15(10):1574-1575; doi:10.1093/annonc/mdh394
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tripathy, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tripathy, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 European Society for Medical Oncology

Reply to Letter to the Editor on "The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer", by G. Utkan, A. Büyükçelik, B. Yalçyn (Ann Oncol 2004; 15: 1574)

The first 10% of the full text of this article appears below.

In response to Dr Utkan and colleagues [1Go] regarding the mortality incidence we reported with oral ibandronate in a 2-year phase III trial [2Go], . . . [Full Text of this Article]

D. Tripathy*

University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8852, USA

* ); Email: debu.tripathy@utsouthwestern.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
D. Tripathy
Reply to Letter to the Editor on "The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer", by G. Utkan, A. Buyukcelik, B. Yalcyn (Ann Oncol 2004; 15: 1574)
Ann. Onc., October 1, 2004; 15(10): 1574 - 1575.
[Full Text] [PDF]